IP Library Granted Patent US 11,758,909
Granted Patent B2
US 11,758,909 · App. 16/719,308 · Granted Sep 19, 2023

Antimicrobial nonwoven polyamides with zinc content

Inventors: Scott E. Osborn (Pensacola, FL); Wai-shing Yung (Pensacola, FL); Albert Ortega (Pensacola, FL)
Assignee: Ascend Performance Materials Operations LLC
A01N57/00A01N59/16D01D5/0985D01F8/12D04H1/4334D04H3/009D10B2331/02D10B2401/13Y10T442/607
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,758,909
App. No.
16/719,308
Granted
Sep 19, 2023
Kind
B2
Abstract

The present disclosure relates to a nonwoven polyamide structure having antimicrobial properties comprising: nonwoven polyamide fibers comprising less than 4000 ppm zinc dispersed within the nonwoven polyamide fibers; and less than 2000 ppm phosphorus. The fibers have an average fiber diameter of less than 25 microns; and the polyamide structure demonstrates a Staphylococcus Aureus reduction of at least 90%, as measured by ISO 20743-13.

Claims (42)

1. A nonwoven polyamide structure having antimicrobial properties comprising:

nonwoven polyamide fibers comprising a polyamide composition comprising:

less than 4000 ppm zinc dispersed within the nonwoven polyamide fibers; and

less than 2000 ppm phosphorus,

wherein the fibers have an average fiber diameter of less than 20 microns;

wherein the zinc is provided via a zinc compound and the phosphorus is provided via a phosphorus compound different from the zinc compound; and

wherein the polyamide structure demonstrates a Staphylococcus Aureus reduction of at least 90%, as measured by ISO 20743-13.

2. The nonwoven polyamide structure of claim 1 , wherein the weight ratio of the zinc to the phosphorus is at least 1.3:1; or less than 0.64:1.

3. The nonwoven polyamide structure of claim 1 , wherein the relative viscosity of the polyamide composition is less than 100.

4. The nonwoven polyamide structure of claim 1 , wherein the polyamide composition comprises less than 3100 ppm of zinc, wherein the polyamide composition comprises a delusterant including at least a portion of the phosphorus, and wherein the polyamide demonstrates a Staphylococcus Aureus reduction of at least 90%, as measured by ISO 20743-13.

5. The nonwoven polyamide structure of claim 1 , wherein no more than 20% of the fibers have a diameter of greater than 700 nanometers.

6. The nonwoven polyamide structure of claim 1 , wherein the polyamide comprises nylon 66 or nylon 6/66.

7. Antimicrobial fibers having antimicrobial properties comprising:

a polymer;

less than 4000 ppm zinc dispersed within the polymer; and

less than 2000 ppm phosphorus,

wherein the fibers have an average fiber diameter of less than 20 microns;

wherein the zinc is provided via a zinc compound and the phosphorus is provided via a phosphorus compound different from the zinc compound; and

wherein the antimicrobial fibers demonstrate a Staphylococcus Aureus reduction of at least 90%, as measured by ISO 20743-13.

8. The antimicrobial fibers of claim 7 , wherein the weight ratio of zinc to phosphorus is: at least 1.3:1; or less than 0.64:1.

9. The antimicrobial fibers of claim 7 , wherein the antimicrobial fibers comprise less than 3100 ppm of zinc.

10. The antimicrobial fibers of claim 7 , wherein the antimicrobial fibers have a zinc retention greater than 70% as measured by a dye bath test.

11. The antimicrobial fibers of claim 7 , wherein the antimicrobial fibers comprise less than 3200 ppm of zinc, wherein the antimicrobial fibers comprise a delusterant including at least a portion of the phosphorus, and wherein the antimicrobial fibers demonstrates a Staphylococcus Aureus reduction of at least 90%, as measured by ISO 20743-13.

12. The antimicrobial fibers of claim 7 , wherein the antimicrobial fibers comprise nylon 66 or nylon 6/66.

13. A process for preparing an antimicrobial nonwoven polyamide structure having permanent antimicrobial properties, the process comprising:

preparing precursor polyamide comprising an aqueous monomer solution;

dispersing less than 4000 ppm zinc within the precursor polyamide;

dispersing less than 2000 ppm phosphorus within the precursor polyamide;

wherein the zinc is provided via a zinc compound and the phosphorus is provided via a phosphorus compound different from the zinc compound;

polymerizing the precursor polyamide to form a polyamide composition;

spinning the polyamide composition to form antimicrobial polyamide fibers; and

forming the antimicrobial polyamide fibers into the antimicrobial nonwoven structure having a fiber diameter of less than 20 microns; and

wherein the polyamide structure demonstrates a Staphylococcus Aureus reduction of at least 90%, as measured by ISO 20743-13.

14. The process of claim 13 , wherein the antimicrobial nonwoven polyamides have a zinc retention greater than 70% as measured by a dye bath test.

15. The process of claim 13 , wherein the weight ratio of zinc to phosphorus is: at least 1.3:1 or less than 0.64:1.

16. The process of claim 13 , wherein the polyamide is melt spun by way of melt blowing through a die into a high velocity gaseous stream.

17. A process for preparing an antimicrobial nonwoven polyamide structure having antimicrobial properties, the process comprising:

preparing a formulation comprising a polyamide, less than 4000 ppm zinc dispersed within the polyamide; and less than 2000 ppm phosphorus dispersed within the polyamide, wherein the zinc is provided via a zinc compound and the phosphorus is provided via a phosphorus compound different from the zinc compound;

spinning the formulation to form antimicrobial polyamide fibers having a fiber diameter c less than 20 microns; and

forming the antimicrobial polyamide fibers into antimicrobial nonwoven polyamide structure;

wherein the fibers were spun using a die pressure less than 275 psig; and

wherein the polyamide structure demonstrates a Staphylococcus Aureus reduction of at least 90%, as measured by ISO 20743-13.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Dec 23, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: ASCEND PERFORMANCE MATERIALS OPERATIONS LLC
Reel/Frame 074050/0090 →
SECURITY INTEREST Recorded Dec 23, 2025
From: ASCEND PERFORMANCE MATERIALS OPERATIONS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 074056/0183 →
SECURITY INTEREST Recorded Dec 19, 2025
From: ASCEND PERFORMANCE MATERIALS OPERATIONS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 074007/0183 →
SECURITY INTEREST Recorded Apr 10, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 070811/0705 →
SECURITY INTEREST Recorded Dec 8, 2022
From: ASCEND PERFORMANCE MATERIALS OPERATIONS LLC
To: WELLS FARGO CAPITAL FINANCE, LLC
Reel/Frame 062094/0172 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2020
From: OSBORN, SCOTT E.; YUNG, WAI-SHING; ORTEGA, ALBERT
To: ASCEND PERFORMANCE MATERIALS OPERATIONS LLC
Reel/Frame 051990/0772 →